Cargando…
A Canadian Prospective Study of Linkage of Randomized Clinical Trial to Cancer and Mortality Registry Data
In a prospective study, we sought to determine acceptability of linkage of administrative and clinical trial data among Canadian patients and Research Ethics Boards (REBs). The goal is to develop a more harmonized approach to data, with potential to improve clinical trial conduct through enhanced da...
Autores principales: | Hay, Annette E, Mittmann, Nicole, Crump, Michael, Cheung, Matthew C, Sleeth, Jessica, Needham, Judy, Broekhoven, Mike, Djurfeldt, Marina, Shepherd, Lois E, Meyer, Ralph M, Chen, Bingshu E, Pater, Joseph L |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8025743/ https://www.ncbi.nlm.nih.gov/pubmed/33800281 http://dx.doi.org/10.3390/curroncol28020111 |
Ejemplares similares
-
Evaluating the Indirect Costs of Care Associated with Salvage Chemotherapy for Relapsed and Refractory Aggressive-Histology Lymphoma: A Subset Analysis of the Canadian Cancer Trials Group (CCTG) LY.12 Clinical Trial
por: Prica, Anca, et al.
Publicado: (2021) -
Contact Days Associated With Cancer Treatments in the CCTG LY.12 Trial
por: Gupta, Arjun, et al.
Publicado: (2023) -
Minimization of resource utilization data collected within cost-effectiveness analyses conducted alongside Canadian Cancer Trials Group phase III trials
por: Cheung, Matthew C, et al.
Publicado: (2021) -
Advantages of the net benefit regression framework for trial-based economic evaluations of cancer treatments: an example from the Canadian Cancer Trials Group CO.17 trial
por: Hoch, Jeffrey S., et al.
Publicado: (2019) -
Power and sample size calculation for incremental net benefit in cost effectiveness analyses with applications to trials conducted by the Canadian Cancer Trials Group
por: Everest, Louis, et al.
Publicado: (2023)